Sodium Stibogluconate With Interferon Alpha-2b for Patients With Advanced Malignancies

NCT00629200 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Advanced Cancer
Solid Tumors

Interventions

DRUG: Sodium Stibogluconate
DRUG: Interferon Alpha-2b

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]